Erik Dubberke, MD, MSPH

Dr. Dubberke is an Associate Professor of Medicine at Washington University School of Medicine in St. Louis, where he has been a faculty member in the Division of Infectious Diseases since 2005. He is an Associate Hospital Epidemiologist at Barnes-Jewish Hospital, Medical Director of Infection Control at Missouri Baptist Medical Center, and is the Director of the Section of Transplant Infectious Diseases at Washington University. He attended medical school at University of Illinois at Chicago, and did his medicine and infectious diseases training at Barnes-Jewish Hospital/Washington University. He received a Master’s of Science in Public Health from St. Louis University. His main research interests are in the epidemiology, diagnosis, treatment, and prevention of Clostridium difficile infection (CDI) and multidrug resistant organisms (MDRO), and his main clinical interest is prevention and treatment of infections in transplant recipients. Dr. Dubberke has over 110 publications related to CDI, MDRO, and infections in transplant recipients, and his research has been funded by the CDC, AHRQ, NINR, NIDDK, NIAID, private foundations and industry. He made the Thomson Reuters list of Highly Cited Researchers in 2015 and 2016. He was the lead author of the CDI component of the Society for Healthcare Epidemiology of America (SHEA) Compendium to Prevent Healthcare Associated Infections, and is on the panel updating the SHEA/IDSA CDI clinical guidelines. He has also represented SHEA as a Key Informant for the AHRQ Evidence-based Practice Center C. difficile review and at the Department of Health and Human Services Road Map to Eliminate HAI 2013 Action Plan Conference. He also is an author of the NCCN Prevention and Treatment of Cancer-Related Infection Guidelines, and CDC-sponsored guidelines on prevention and treatment of infections in HCT recipients.